Company Overview of Cognosci Inc.
Cognosci Inc. engages in discovering and developing anti-inflammatory compounds for the treatment of neuroinflammatory diseases. Its products include COG112 to treat multiple sclerosis; and COG1410 to treat traumatic brain injuries and Alzheimer’s disease. The company also offers products to treat ischemic stroke/subarachnoid hemorrhage, spinal cord injury, Parkinson's disease, rheumatoid arthritis, and sepsis. Cognosci was founded in 2000 and is based in Research Triangle Park, North Carolina.
79 T. W. Alexander Drive
4401 Research Commons
Research Triangle Park, NC 27709
Founded in 2000
Key Executives for Cognosci Inc.
Similar Private Companies By Industry
|Scandinavian BioPharma AS||United States|
|Schiff Nutrition Group, Inc.||United States|
|Victory Pharma, Inc.||United States|
|Standard Homeopathic Company||United States|
|Prolab Nutrition, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- Florham Park, NJ | PwCPosted: Aug 20
- Philadelphia, PA | PwCPosted: Aug 20
- New York, NY | PwCPosted: Aug 20
- Chicago, IL | PwCPosted: Aug 20
Sponsored Financial Commentaries
To contact Cognosci Inc., please visit www.cognosci.com. Company data is provided by Capital IQ. Please use this form to report any data issues.